Galactol Supplementation and Low-FODMAP Diet for IBS Symptoms

This study focuses on Irritable Bowel Syndrome (IBS), a common disorder that often causes abdominal bloating and other intestinal symptoms after eating. Certain foods, especially those high in specific types of carbohydrates and gluten-related peptides, can worsen these symptoms. While dietary restrictions are commonly used to manage IBS, they can be challenging to maintain. This study explores an alternative approach: using a dietary supplement called Galactol®, which contains enzymes that help break down these problematic foods, potentially reducing intestinal discomfort. Adults diagnosed with IBS and experiencing food-related abdominal bloating are invited to participate. The study's goal is to determine if enzyme supplementation can improve food-related gastrointestinal symptoms in IBS patients. Participants will be randomly divided into two groups. One group will receive Galactol® supplementation along with a diet that excludes foods high in specific carbohydrates and gluten-related peptides, while the other group will follow the diet alone. The treatment period will last for 14 days. At the beginning and end of the treatment, assessments will be conducted to evaluate the intensity of abdominal bloating, additional gastrointestinal symptoms, stool consistency, frequency of bowel movements, episodes of diarrhea, overall gastrointestinal well-being, and treatment safety and tolerability. The primary outcome of the study is the change in post-meal abdominal bloating intensity, measured on a scale from 0 (no symptoms) to 10 (worst symptoms).